APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Morphine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Morphine Market Outlook and Growth Opportunities 2026

Report ID 174014340421 December 2025198 pages

Choose your research edition.

Industry ResearchMorphine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Morphine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Morphine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morphine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Morphine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Morphine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Morphine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Morphine market include Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, Sanofi Winthrop Industrie, Purdue Pharma, Mallinckrodt Pharmaceuticals, Macfarlan Smith and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Morphine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Morphine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Morphine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morphine market size, projected growth trends, production technologies, key applications, and end-use industries.

Morphine Segment by Company

Sun Pharmaceutical Industries

Qinghai Pharmaceutical

Northeast Pharmaceutical Group

Sanofi Winthrop Industrie

Purdue Pharma

Mallinckrodt Pharmaceuticals

Macfarlan Smith

Alcaliber

Morphine Segment by Type

Injection

Oral Tablets

Capsule

Others

Morphine Segment by Application

Diarrhea Suppressant

Cough Suppressant

Anesthesia

Morphine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Morphine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Morphine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Morphine significant trends, drivers, influence factors in global and regions.

6. To analyze Morphine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Morphine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morphine industry.

Chapter 3: Detailed analysis of Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Morphine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Morphine Industry Trends Table 2. Morphine Industry Drivers Table 3. Morphine Industry Opportunities and Challenges Table 4. Morphine Industry Restraints Table 5. Global Morphine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Morphine Revenue Share by Company (2021-2026) Table 7. Global Morphine Sales Volume by Company (tons) & (2021-2026) Table 8. Global Morphine Sales Volume Share by Company (2021-2026) Table 9. Global Morphine Average Price (US$/ton) of Company (2021-2026) Table 10. Global Morphine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Morphine Key Company Manufacturing Base & Headquarters Table 12. Global Morphine Company, Product Type & Application Table 13. Global Morphine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Morphine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Oral Tablets Table 19. Significant Companies of Capsule Table 20. Significant Companies of Others Table 21. Global Morphine Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Morphine Sales Volume by Type (2021-2026) & (tons) Table 23. Global Morphine Sales Volume by Type (2027-2032) & (tons) Table 24. Global Morphine Sales Volume Share by Type (2021-2026) Table 25. Global Morphine Sales Volume Share by Type (2027-2032) Table 26. Global Morphine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Morphine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Morphine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Morphine Sales Value Share by Type (2021-2026) Table 30. Global Morphine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Diarrhea Suppressant Table 32. Significant Companies of Cough Suppressant Table 33. Significant Companies of Anesthesia Table 34. Global Morphine Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 35. Global Morphine Sales Volume by Application (2021-2026) & (tons) Table 36. Global Morphine Sales Volume by Application (2027-2032) & (tons) Table 37. Global Morphine Sales Volume Share by Application (2021-2026) Table 38. Global Morphine Sales Volume Share by Application (2027-2032) Table 39. Global Morphine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Morphine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Morphine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Morphine Sales Value Share by Application (2021-2026) Table 43. Global Morphine Sales Value Share by Application (2027-2032) Table 44. Global Morphine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 45. Global Morphine Sales by Region (2021-2026) & (tons) Table 46. Global Morphine Sales Market Share by Region (2021-2026) Table 47. Global Morphine Sales by Region (2027-2032) & (tons) Table 48. Global Morphine Sales Market Share by Region (2027-2032) Table 49. Global Morphine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Morphine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Morphine Sales Value Share by Region (2021-2026) Table 52. Global Morphine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Morphine Sales Value Share by Region (2027-2032) Table 54. Global Morphine Market Average Price (US$/ton) by Region (2021-2026) Table 55. Global Morphine Market Average Price (US$/ton) by Region (2027-2032) Table 56. Global Morphine Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Global Morphine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Morphine Sales by Country (2021-2026) & (tons) Table 59. Global Morphine Sales Market Share by Country (2021-2026) Table 60. Global Morphine Sales by Country (2027-2032) & (tons) Table 61. Global Morphine Sales Market Share by Country (2027-2032) Table 62. Global Morphine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Morphine Sales Value Market Share by Country (2021-2026) Table 64. Global Morphine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Morphine Sales Value Market Share by Country (2027-2032) Table 66. Sun Pharmaceutical Industries Company Information Table 67. Sun Pharmaceutical Industries Business Overview Table 68. Sun Pharmaceutical Industries Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 69. Sun Pharmaceutical Industries Morphine Product Portfolio Table 70. Sun Pharmaceutical Industries Recent Development Table 71. Qinghai Pharmaceutical Company Information Table 72. Qinghai Pharmaceutical Business Overview Table 73. Qinghai Pharmaceutical Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Qinghai Pharmaceutical Morphine Product Portfolio Table 75. Qinghai Pharmaceutical Recent Development Table 76. Northeast Pharmaceutical Group Company Information Table 77. Northeast Pharmaceutical Group Business Overview Table 78. Northeast Pharmaceutical Group Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Northeast Pharmaceutical Group Morphine Product Portfolio Table 80. Northeast Pharmaceutical Group Recent Development Table 81. Sanofi Winthrop Industrie Company Information Table 82. Sanofi Winthrop Industrie Business Overview Table 83. Sanofi Winthrop Industrie Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Sanofi Winthrop Industrie Morphine Product Portfolio Table 85. Sanofi Winthrop Industrie Recent Development Table 86. Purdue Pharma Company Information Table 87. Purdue Pharma Business Overview Table 88. Purdue Pharma Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Purdue Pharma Morphine Product Portfolio Table 90. Purdue Pharma Recent Development Table 91. Mallinckrodt Pharmaceuticals Company Information Table 92. Mallinckrodt Pharmaceuticals Business Overview Table 93. Mallinckrodt Pharmaceuticals Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Mallinckrodt Pharmaceuticals Morphine Product Portfolio Table 95. Mallinckrodt Pharmaceuticals Recent Development Table 96. Macfarlan Smith Company Information Table 97. Macfarlan Smith Business Overview Table 98. Macfarlan Smith Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Macfarlan Smith Morphine Product Portfolio Table 100. Macfarlan Smith Recent Development Table 101. Alcaliber Company Information Table 102. Alcaliber Business Overview Table 103. Alcaliber Morphine Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Alcaliber Morphine Product Portfolio Table 105. Alcaliber Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Morphine Distributors List Table 109. Morphine Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Morphine Product Image Figure 2. Global Morphine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morphine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Morphine Sales (2021-2032) & (tons) Figure 5. Global Morphine Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Morphine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Oral Tablets Image Figure 11. Capsule Image Figure 12. Others Image Figure 13. Global Morphine Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Morphine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Morphine Sales Volume Share by Type (2021-2032) Figure 16. Global Morphine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Morphine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Morphine Sales Value Share by Type (2021-2032) Figure 19. Diarrhea Suppressant Image Figure 20. Cough Suppressant Image Figure 21. Anesthesia Image Figure 22. Global Morphine Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Morphine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Morphine Sales Volume Share by Application (2021-2032) Figure 25. Global Morphine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Morphine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Morphine Sales Value Share by Application (2021-2032) Figure 28. Global Morphine Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 29. Global Morphine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Morphine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Morphine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Morphine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Morphine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Morphine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Morphine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Morphine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Morphine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Morphine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Tablets
  • Capsule
  • Others
Applications
  • Diarrhea Suppressant
  • Cough Suppressant
  • Anesthesia
Companies covered
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical Group
  • Sanofi Winthrop Industrie
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Macfarlan Smith
  • Alcaliber

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Morphine Sales Value (2021-2032)
  4. 1.2.2 Global Morphine Sales Volume (2021-2032)
  5. 1.2.3 Global Morphine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Morphine Market Dynamics
  1. 2.1 Morphine Industry Trends
  2. 2.2 Morphine Industry Drivers
  3. 2.3 Morphine Industry Opportunities and Challenges
  4. 2.4 Morphine Industry Restraints
3 Morphine Market by Company
  1. 3.1 Global Morphine Company Revenue Ranking in 2025
  2. 3.2 Global Morphine Revenue by Company (2021-2026)
  3. 3.3 Global Morphine Sales Volume by Company (2021-2026)
  4. 3.4 Global Morphine Average Price by Company (2021-2026)
  5. 3.5 Global Morphine Company Ranking (2024-2026)
  6. 3.6 Global Morphine Company Manufacturing Base and Headquarters
  7. 3.7 Global Morphine Company Product Type and Application
  8. 3.8 Global Morphine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Morphine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Morphine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Morphine Market by Type
  1. 4.1 Morphine Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Oral Tablets
  4. 4.1.3 Capsule
  5. 4.1.4 Others
  6. 4.2 Global Morphine Sales Volume by Type
  7. 4.2.1 Global Morphine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Morphine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Morphine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Morphine Sales Value by Type
  11. 4.3.1 Global Morphine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Morphine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Morphine Sales Value Share by Type (2021-2032)
5 Morphine Market by Application
  1. 5.1 Morphine Application Introduction
  2. 5.1.1 Diarrhea Suppressant
  3. 5.1.2 Cough Suppressant
  4. 5.1.3 Anesthesia
  5. 5.2 Global Morphine Sales Volume by Application
  6. 5.2.1 Global Morphine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Morphine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Morphine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Morphine Sales Value by Application
  10. 5.3.1 Global Morphine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Morphine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Morphine Sales Value Share by Application (2021-2032)
6 Morphine Regional Sales and Value Analysis
  1. 6.1 Global Morphine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Morphine Sales by Region (2021-2032)
  3. 6.2.1 Global Morphine Sales by Region: 2021-2026
  4. 6.2.2 Global Morphine Sales by Region (2027-2032)
  5. 6.3 Global Morphine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Morphine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Morphine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Morphine Sales Value by Region (2027-2032)
  9. 6.5 Global Morphine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Morphine Sales Value (2021-2032)
  12. 6.6.2 North America Morphine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Morphine Sales Value (2021-2032)
  15. 6.7.2 Europe Morphine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Morphine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Morphine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Morphine Sales Value (2021-2032)
  21. 6.9.2 South America Morphine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Morphine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Morphine Sales Value Share by Country, 2025 VS 2032
7 Morphine Country-level Sales and Value Analysis
  1. 7.1 Global Morphine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Morphine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Morphine Sales by Country (2021-2032)
  4. 7.3.1 Global Morphine Sales by Country (2021-2026)
  5. 7.3.2 Global Morphine Sales by Country (2027-2032)
  6. 7.4 Global Morphine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Morphine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Morphine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Morphine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Morphine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Morphine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Morphine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Morphine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Morphine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Morphine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Morphine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Morphine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Morphine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Morphine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Morphine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Morphine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Morphine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Morphine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Morphine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Morphine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Morphine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Morphine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Morphine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Morphine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Morphine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Morphine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Morphine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Morphine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Morphine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Morphine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Morphine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Morphine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Morphine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Morphine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Morphine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Morphine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Morphine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Morphine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Morphine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Morphine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Morphine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Morphine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Morphine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Morphine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Morphine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Morphine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Morphine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Morphine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Morphine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Morphine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Morphine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Morphine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Morphine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Morphine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Morphine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Morphine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Morphine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Morphine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Morphine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Morphine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Morphine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Morphine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Morphine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Morphine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Morphine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Morphine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Morphine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Morphine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Morphine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Morphine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Morphine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Morphine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Morphine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Morphine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Morphine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Morphine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Morphine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Morphine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Morphine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Morphine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Morphine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Morphine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Morphine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Morphine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Morphine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Morphine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Morphine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Morphine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Morphine Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Qinghai Pharmaceutical
  8. 8.2.1 Qinghai Pharmaceutical Company Information
  9. 8.2.2 Qinghai Pharmaceutical Business Overview
  10. 8.2.3 Qinghai Pharmaceutical Morphine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qinghai Pharmaceutical Morphine Product Portfolio
  12. 8.2.5 Qinghai Pharmaceutical Recent Developments
  13. 8.3 Northeast Pharmaceutical Group
  14. 8.3.1 Northeast Pharmaceutical Group Company Information
  15. 8.3.2 Northeast Pharmaceutical Group Business Overview
  16. 8.3.3 Northeast Pharmaceutical Group Morphine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Northeast Pharmaceutical Group Morphine Product Portfolio
  18. 8.3.5 Northeast Pharmaceutical Group Recent Developments
  19. 8.4 Sanofi Winthrop Industrie
  20. 8.4.1 Sanofi Winthrop Industrie Company Information
  21. 8.4.2 Sanofi Winthrop Industrie Business Overview
  22. 8.4.3 Sanofi Winthrop Industrie Morphine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
  24. 8.4.5 Sanofi Winthrop Industrie Recent Developments
  25. 8.5 Purdue Pharma
  26. 8.5.1 Purdue Pharma Company Information
  27. 8.5.2 Purdue Pharma Business Overview
  28. 8.5.3 Purdue Pharma Morphine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Purdue Pharma Morphine Product Portfolio
  30. 8.5.5 Purdue Pharma Recent Developments
  31. 8.6 Mallinckrodt Pharmaceuticals
  32. 8.6.1 Mallinckrodt Pharmaceuticals Company Information
  33. 8.6.2 Mallinckrodt Pharmaceuticals Business Overview
  34. 8.6.3 Mallinckrodt Pharmaceuticals Morphine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
  36. 8.6.5 Mallinckrodt Pharmaceuticals Recent Developments
  37. 8.7 Macfarlan Smith
  38. 8.7.1 Macfarlan Smith Company Information
  39. 8.7.2 Macfarlan Smith Business Overview
  40. 8.7.3 Macfarlan Smith Morphine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Macfarlan Smith Morphine Product Portfolio
  42. 8.7.5 Macfarlan Smith Recent Developments
  43. 8.8 Alcaliber
  44. 8.8.1 Alcaliber Company Information
  45. 8.8.2 Alcaliber Business Overview
  46. 8.8.3 Alcaliber Morphine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Alcaliber Morphine Product Portfolio
  48. 8.8.5 Alcaliber Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Morphine Value Chain Analysis
  2. 9.1.1 Morphine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Morphine Sales Mode & Process
  6. 9.2 Morphine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Morphine Distributors
  9. 9.2.3 Morphine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst